Chenghao Wang

机构：University of Electronic Science and Technology of China, China Pharmaceutical University, Guangdong Pharmaceutical University, Anhui Medical University, Chinese Academy of Sciences, Institute of Acoustics, Sichuan Cancer Hospital, Second Affiliated Hospital of Anhui Medical University, Jiangsu Province Hospital, Shenzhen Second People's Hospital, Nanjing Medical University · ORCID：0000-0002-6730-1022

发表论文 51 篇 · 总被引 875 次 · h-index 14

代表论文

Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy (2023 · Journal of Medicinal Chemistry · 被引 20)
Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis (2024 · Annals of Surgical Oncology · 被引 19)
Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study (2025 · BMC Gastroenterology · 被引 16)
Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis (2024 · Journal of Gastrointestinal Surgery · 被引 11)
Long-term outcomes of smoker and drinker with oesophageal squamous cell carcinoma after oesophagectomy: a large-scale propensity score matching analysis (2024 · BMJ Open Gastroenterology · 被引 10)
Longitudinal patient-reported outcomes after minimally invasive McKeown esophagectomy for patients with esophageal squamous cell carcinoma (2024 · Supportive Care in Cancer · 被引 8)